Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531
CompletedOBSERVATIONAL
Enrollment
1,000
Participants
Timeline
Start Date
July 31, 2011
Primary Completion Date
May 31, 2016
Conditions
Leukemia
Interventions
GENETIC
DNA analysis
GENETIC
gene expression analysis
OTHER
laboratory biomarker analysis
OTHER
pharmacogenomic studies
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Children's Oncology Group
NETWORK
NCT01407757 - Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531 | Biotech Hunter | Biotech Hunter